Back to RHUMBLINE ADVISERS RHUMBLINE ADVISERS

BLRXBLRX
6 quarters

Position history for RHUMBLINE ADVISERSRHUMBLINE ADVISERS's holdings in BIOLINE RX LIMITED

Yes. RhumbLine Advisers holds 2,478 shares of BLRX (Bioline RX), worth $7,679, as of its Q2 2026 13F filing. It increased the position by 125 shares (+5.3%) from Q1 2026. RhumbLine Advisers has held BLRX since Q1 2025, across 6 quarterly 13F filings.

Current Value

$7,679

Current Shares

2,478

Total Value Change

+$3,155

Total Shares Change

+948

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2,478
+5.3%
$7,6790.0%$3.12
12
2026-Q1
Decreased
2,353
-29.8%
$5,4320.0%$2.81
0
2025-Q4
Increased
3,353
+9.2%
$9,5520.0%$2.87
13
2025-Q3
Decreased
3,070
-28.2%
$11,6020.0%$3.76
0
2025-Q2
Increased
4,275
+179.4%
$19,5330.0%$4.43
20
2025-Q1
New
1,530
-
$4,5240.0%$3.05
23

Other major holders of BLRX: CITADEL ADVISORS LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, SIMPLEX TRADING, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used